The effects of mTOR inhibition in ischemic stroke

With a global incidence of 9.5 million cases annually and 56 million disability-adjusted life-years, ischemic stroke is the primary cause of adult disability in developed countries. However, the significant successes in stroke trials have been in the field of reperfusion therapies for ischemic strok...

Повний опис

Бібліографічні деталі
Автор: Schneider, AM
Інші автори: Buchan, A
Формат: Дисертація
Мова:English
Опубліковано: 2022
Предмети: